Sevelamer Hydrochloride for Tumor Lysis Syndrome-related Hyperphosphatemia.

Indian Pediatr

Department of Pediatrics, Kasturba Medical College Hospital, Mangalore (Manipal University), Karnataka, India. Correspondence to: Dr Harsha Prasada L, Department of Pediatrics, Kasturba Medical College Hospital, Mangalore 575 001, Karnataka.

Published: July 2015

AI Article Synopsis

  • Tumour lysis syndrome is characterized by elevated uric acid, phosphate, and potassium levels, alongside decreased calcium and impaired kidney function.
  • Two children with T-cell acute lymphoblastic leukemia developed this syndrome due to high tumor loads.
  • The administration of Sevelamer and Rasburicase successfully normalized serum phosphate levels in both patients within 24-48 hours, indicating Sevelamer's efficacy in treating hyperphosphatemia related to tumour lysis syndrome.

Article Abstract

Background: Tumour lysis syndrome is associated with high levels of uric acid, phosphate and potassium along with low levels of calcium and abnormal renal function. Sevelamer, an oral phosphate-binder is used in the treatment of hyperphosphatemia in children and adults on hemodialysis.

Case Characteristics: Two children with T-cell acute lymphoblastic leukemia who presented with a high tumour load and developed tumour lysis syndrome.

Observation: Both children received Rasburicase and Sevelamer hydrochloride. The serum phosphate reduced to normal levels within 24-48 hrs of initiation of sevelamer hydrochloride.

Message: Sevelamer appears to be an effective treatment for hyperphosphatemia associated with tumour lysis syndrome.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13312-015-0686-yDOI Listing

Publication Analysis

Top Keywords

tumour lysis
12
sevelamer hydrochloride
8
lysis syndrome
8
treatment hyperphosphatemia
8
sevelamer
5
hydrochloride tumor
4
lysis
4
tumor lysis
4
lysis syndrome-related
4
syndrome-related hyperphosphatemia
4

Similar Publications

Background: Cholangiocarcinoma is a challenging malignancy with limited responses to conventional therapies, particularly immune checkpoint inhibitor therapy. Tumor-infiltrating lymphocytes (TILs) and tertiary lymphoid structures (TLSs) are key components of the tumor microenvironment (TME) and have been implicated in the immune response to cancer. However, the role and difference of TLSs and TILs in patients with cholangiocarcinoma remains unclear.

View Article and Find Full Text PDF

: Developing ex vivo models that replicate immune-tumor interactions with high fidelity is essential for advancing immunotherapy research, as traditional two-dimensional in vitro systems often lack the complexity required to fully represent these interactions. : In this study, we establish a comprehensive 3D redirect lysis (3D-RDL) assay using colorectal cancer spheroids and adult stem cell-derived, healthy human organoids to evaluate the efficacy and safety profile of , a bispecific antibody targeting carcinoembryonic antigens (CEAs) on cancer cells and CD3 on T cells. This model allows us to assess cytotoxic activity and immune responses, capturing variations in therapeutic response not observable in simpler systems.

View Article and Find Full Text PDF

Nanosheet-shaped WS/ICG nanocomposite for photodynamic/photothermal synergistic bacterial clearance and cutaneous regeneration on infectious wounds.

Biomater Adv

January 2025

Key Laboratory of Tropical Translational Medicine of Ministry of Education, Hainan Medical University-The University of Hong Kong Joint Laboratory of Tropical Infectious Diseases, School of Basic Medical Sciences and Life Sciences, Hainan Medical University, Haikou 571199, China. Electronic address:

Bacterial infections present a significant threat to human health, a challenge that is intensified by the slow pace of novel antibiotic development and the swift emergence of bacterial resistance. The development of novel antibacterial agents is crucial. Indocyanine green (ICG), a widely used imaging dye, efficiently generates reactive oxygen species (ROS) and heat for treating bacterial infections but suffers from aggregation and instability, limiting its efficacy.

View Article and Find Full Text PDF

Gout is a disease caused by the deposit of monosodium urate (MSU) crystals that produce joint inflammation and subcutaneous nodules (tophi). The treatment of gout aims to reduce serum uric acid (sUA) levels by administering urate-lowering therapies (ULT) such as xanthine oxidase inhibitors (XOI: allopurinol, febuxostat) or uricosurics (e.g.

View Article and Find Full Text PDF

The emergence of DNAM-1 as the facilitator of NK cell-mediated killing in ovarian cancer.

Front Immunol

January 2025

Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.

Introduction: Ovarian cancer (OC) is the sixth most common malignancy in women and the poor 5-year survival emphasises the need for novel therapies. NK cells play an important role in the control of malignant disease but the nature of tumour-infiltrating and peripheral NK cells in OC remains unclear.

Methods: Using flow cytometric analysis, we studied the phenotype and function of NK cells in blood, primary tumour and metastatic tissue in 80 women with OC.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!